Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer.
about
Ribonucleotide reductase inhibition restores platinum-sensitivity in platinum-resistant ovarian cancer: a Gynecologic Oncology Group Study.Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.
P2860
Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@ast
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@en
type
label
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@ast
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@en
prefLabel
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@ast
Phase II study of gemcitabine ...... ent epithelial ovarian cancer.
@en
P2093
P1476
Phase II study of gemcitabine ...... rent epithelial ovarian cancer
@en
P2093
Hui-fang Huang
Jia-xin Yang
Jing-he Lang
Ling-ya Pan
P304
P577
2007-09-01T00:00:00Z